Assertio Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results After The Close of Markets on Wednesday, ...
February 21 2019 - 4:05PM
Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it
will release fourth quarter and full year 2018 financial results on
Wednesday, March 6, 2019, after the close of markets. Following the
announcement, the Company will host a conference call beginning at
4:30 p.m. ET to discuss its results.
Participants can access the live webcast from the Investor
Relations section of Assertio's website at
http://investor.assertiotx.com. Please access the website 15
minutes prior to the start of the call to download and install any
necessary audio software.
Audio Conference Call:
U.S. Dial-in Number: |
1-877-550-3745 |
International Dial-in Number: |
1-281-973-6277 |
Conference ID: |
3784827 |
An archived webcast replay will be available on the Company's
website accessed by visiting http://investor.assertiotx.com.
About Assertio Therapeutics, Inc.Assertio
Therapeutics is committed to providing responsible solutions to
advance patient care in the Company’s core areas of neurology,
orphan and specialty medicines. Assertio currently markets three
FDA-approved products and continues to identify, license and
develop new products that offer enhanced options for patients that
may be underserved by existing therapies. To learn more about
Assertio, visit www.assertiotx.com.
Investor and Media Contact:John B. Thomas
Senior Vice President, Investor Relations and Corporate
Communications jthomas@assertiotx.com
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Sep 2023 to Sep 2024